
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
- Cheque size
- $1M – $20M
- Stages
- Industries
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

